Category: Regulatory/FDA

MMM Previews Pharma Debates in DC: Prepare for a Wild Ride in 2012

Increased Funding for FDA Is a Result of Industry, Consumer Efforts

CMPI Hosting Panel to Discuss PDUFA Without Politics

FDA Approval Report Contains Good News for Patients and Industry

RPM Report: Pandora’s Box Officially Open as New Legal Challenges to FDA’s Off-label Restrictions Emerge

Par Pharma Case Asserts That First Amendment Protects Truthful Off-label Speech

Pitts on the Politics of Drug Industry Sponsorship

Kamp on the Sunshine Act: Collaboration Key to Patient Care

Patients Need Education on Value of New Drugs